{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:08:27Z","timestamp":1782310107564,"version":"3.54.5"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:p>This study evaluates the effectiveness of individualized low-protein diet (ILPD) nursing in patients with multiple myeloma (MM) complicated by renal impairment. A total of 126 MM patients with renal impairment admitted between August 2023 and July 2024 were retrospectively analyzed. Patients received either ILPD nursing (ILPD, n\u2005=\u200564) or routine diet nursing (control, n\u2005=\u200562). Nutritional status, renal function, inflammation, quality of life, and adverse events were compared between groups. After 1 year, the ILPD group showed improved albumin levels, stable body mass index, better renal function, reduced C-reactive protein, and higher quality of life scores, with fewer adverse events compared to controls. ILPD nursing significantly benefits renal function, nutrition, and quality of life while reducing adverse events in MM patients with renal impairment, representing a feasible and effective management strategy.<\/jats:p>","DOI":"10.1097\/md.0000000000046087","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:02:33Z","timestamp":1765814553000},"page":"e46087","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Application of individualized low-protein diet nursing for managing multiple myeloma patients with renal impairment"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiao","family":"Ling","sequence":"first","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6118-0960","authenticated-orcid":false,"given":"Meimei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/ajh.26590","article-title":"Multiple myeloma: 2022 update on diagnosis, risk stratification, and management.","volume":"97","author":"Rajkumar","year":"2022","journal-title":"Am J Hematol"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1016\/S1470-2045(23)00223-1","article-title":"Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group.","volume":"24","author":"Dimopoulos","year":"2023","journal-title":"Lancet Oncol"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-0609.1994.tb00190.x","article-title":"Renal function in newly diagnosed multiple myeloma\u2014a demographic study of 1353 patients.","volume":"53","author":"Knudsen","year":"1994","journal-title":"Eur J Haematol"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/nrneph.2011.168","article-title":"The pathogenesis and diagnosis of acute kidney injury in multiple myeloma.","volume":"8","author":"Hutchison","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.ajkd.2007.05.007","article-title":"Renal manifestations of plasma cell disorders.","volume":"50","author":"Leung","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1200\/JCO.2009.22.2232","article-title":"VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA study.","volume":"27","author":"Dimopoulos","year":"2009","journal-title":"J Clin Oncol"},{"issue":"3 Suppl 1","key":"R7-20251215","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update.","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/j.ajkd.2024.08.003","article-title":"KDOQI US commentary on the KDIGO 2024 clinical practice guideline for the evaluation and management of CKD.","volume":"85","author":"Navaneethan","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"R9-20251215","first-page":"CD001892","article-title":"Low protein diets for non-diabetic adults with chronic kidney disease.","volume":"10","author":"Hahn","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1681\/ASN.2015040369","article-title":"Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression: a RCT.","volume":"27","author":"Garneata","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"118615","DOI":"10.1016\/j.atherosclerosis.2024.118615","article-title":"The dual role of lipids in chronic kidney disease: pathogenic culprits and therapeutic allies.","volume":"398","author":"Giardini","year":"2024","journal-title":"Atherosclerosis"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12882-023-03423-8","article-title":"Effects of a low-protein nutritional formula with dietary counseling in older adults with chronic kidney disease stages 3-5: a randomized controlled trial.","volume":"24","author":"Yang","year":"2023","journal-title":"BMC Nephrol"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1053\/j.jrn.2013.01.001","article-title":"Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the international society of renal nutrition and metabolism (ISRNM).","volume":"23","author":"Carrero","year":"2013","journal-title":"J Ren Nutr"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41581-025-00963-0","article-title":"Drivers and mechanisms of cognitive decline in chronic kidney disease.","volume":"21","author":"Capasso","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients.","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/JCMA.0000000000001280","article-title":"Optimizing care for chronic kidney disease: considerations from A to Z.","volume":"88","author":"Chen","year":"2025","journal-title":"J Chin Med Assoc"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3324\/haematol.2013.087585","article-title":"Bortezomib before\/after ASCT overcomes renal impairment in MM.","volume":"99","author":"Scheid","year":"2014","journal-title":"Haematologica"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/0959-8049(95)00296-0","article-title":"The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy.","volume":"31A","author":"Kaasa","year":"1995","journal-title":"Eur J Cancer"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust.","volume":"69","author":"Giesinger","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2215\/CJN.07420619","article-title":"Proteomics and metabolomics in kidney disease, including insights into etiology, treatment, and prevention.","volume":"15","author":"Dubin","year":"2020","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:02:36Z","timestamp":1765814556000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":20,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046087","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-08-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}